2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Motion Sickness: new trials by email Literature Review of Motion Sickness trials Research Report on Motion Sickness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulizer Delivery of Intranasal Scopolamine Scopolamine, Placebo - Scopolamine, Motion Sickness | Phase 1 | Completed | Dartmouth-Hitchcock Medical Center | 14 | 2022-01-24 | 2025-08-28 |
| A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. Reformulated scopolamine patch, Marketed scopolamine patch - Motion Sickness | Phase 1 | Completed | GlaxoSmithKline | 128 | 2016-05-13 | 2018-05-18 |
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Scopolamine (1)
Dartmouth-Hitchcock Medical Center (1) · GlaxoSmithKline (1)
Canada (1) · United States (1)